Clinical Trial Update: Fluoxetine in Multiple System Atrophy Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating fluoxetine in patients with Multiple System Atrophy has completed, according to the trial update. The snippet lists the sponsor and sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED